11,199 Shares in Azenta, Inc. $AZTA Purchased by Inceptionr LLC

Inceptionr LLC bought a new stake in Azenta, Inc. (NASDAQ:AZTA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,199 shares of the company’s stock, valued at approximately $345,000.

A number of other large investors have also recently bought and sold shares of AZTA. Allianz Asset Management GmbH acquired a new stake in shares of Azenta in the first quarter valued at approximately $301,000. LPL Financial LLC increased its stake in Azenta by 5.9% in the 1st quarter. LPL Financial LLC now owns 53,328 shares of the company’s stock valued at $1,683,000 after buying an additional 2,986 shares during the last quarter. Federated Hermes Inc. increased its stake in Azenta by 1.2% in the 1st quarter. Federated Hermes Inc. now owns 771,091 shares of the company’s stock valued at $26,711,000 after buying an additional 8,902 shares during the last quarter. Jefferies Financial Group Inc. acquired a new position in shares of Azenta during the 1st quarter worth about $1,618,000. Finally, Jupiter Asset Management Ltd. bought a new position in shares of Azenta in the 1st quarter valued at about $2,566,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on AZTA. Jefferies Financial Group upgraded Azenta from a “hold” rating to a “buy” rating and upped their target price for the stock from $30.00 to $38.00 in a report on Thursday, October 30th. Raymond James Financial increased their price objective on Azenta from $35.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday. Zacks Research cut shares of Azenta from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Evercore ISI set a $33.00 price target on shares of Azenta and gave the stock an “in-line” rating in a research report on Tuesday, August 5th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Azenta in a research note on Monday. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $38.60.

Azenta Trading Down 2.1%

AZTA stock opened at $35.53 on Friday. The firm has a market capitalization of $1.63 billion, a PE ratio of -14.68 and a beta of 1.65. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $55.63. The business’s 50 day simple moving average is $31.28 and its 200 day simple moving average is $30.62.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Friday, November 21st. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.01. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%.The business had revenue of $159.19 million during the quarter, compared to the consensus estimate of $156.76 million. During the same quarter last year, the firm posted $0.18 EPS. The company’s quarterly revenue was up 5.7% on a year-over-year basis. As a group, sell-side analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.